Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-16-088708

COO, CLO, and Secretary acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BELBEL CAESAR J COO, CLO, and Secretary 2015-12-31 Grant or award +65,000 124,201 D
Loading xslF345X03/doc4.xml…